Search results
Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
Zacks via Yahoo News· 1 week agoDenali Therapeutics Inc. DNLI is having a good run in 2024. Shares of this biopharmaceutical company...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo News· 1 week agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
La-Z-Boy and Winnebago have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo News· 1 week agoFor Immediate Release Chicago, IL – June 26, 2024 – Zacks Equity Research shares La-Z-Boy LZB as the...
Is the Options Market Predicting a Spike in Biogen (BIIB) Stock?
Zacks via Yahoo News· 2 weeks agoInvestors in Biogen Inc. BIIB need to pay close attention to the stock based on moves in the options...
Biogen Inc. (BIIB) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks via Yahoo News· 2 weeks agoTaking full advantage of the stock market and investing with confidence are common goals for new and...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo News· 1 month agoBiogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo News· 1 month agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo News· 1 month agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
Zacks via Yahoo News· 2 months agoIonis Pharmaceuticals IONS reported a loss of 98 cents per share for first-quarter 2024, which was...
Denali (DNLI) Q1 Earnings Miss, Pipeline Progress in Focus
Zacks via Yahoo News· 2 months agoDenali Therapeutics DNLI incurred a first-quarter 2024 loss of 68 cents per share, wider than the...